treatment | cpnp.org

Home
About CPNP
- Why Join CPNP
- Board of Directors
- Past Presidents
- Committees & Task Forces
- Awards
- CPNP Foundation
- Corporate Sponsorships
  - Sponsor Program
  - Sponsors
- Information for Patients
- Contact CPNP
Education
- April 2013 Annual Meeting in Colorado Springs, CO
- April 2014 Annual Meeting in Phoenix, AZ
- CPNP University Online Courses
- Drug-Induced Movement Disorders Training DVD
- Psychiatric Pharmacotherapy for Nurses
- Other Meetings
- Find More Resources in My CPNP
  - My CPNP Presentations & Exams
  - My CPNP ACPE Transcript Center
BCPP
- BCPP Exam Preparation
  - BCPP Exam Preparation
  - Certification FAQ
- BCPP Recertification
Careers/Residencies
Member Center
- Member Toolkit
- Email List
- Member Directory
- CPNP Documents and Reports
- Member Hubs
  - Pharmacy Student Hub
  - New Practitioner Hub
Resources
Gov't and Prof Affairs
- Comprehensive Medication Management
- Government Affairs
  - Contacting Legislators and Policy Makers
  - Medicare Coverage Initiative with ACCP
- Position/White Papers
  - Psychiatric Pharmacy Manifesto
  - Psychiatric Pharmacist Integration into the Medical Home Model
My CPNP
- Edit My Profile
- My Disclosures of Interest
- My Workspaces
- My Presentations & Exams
- My Volunteer Profile
- My CPNP Transcript Center
- My Opportunities

treatment

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder.

Rivera-Baltanas T, Olivares JM, Calado-Otero M, et al. Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder. J Affect Disord. 2012;137(1-3):46-55. doi:10.1016/j.jad.2011.12.041.

Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression.

Min J-A, Lee N-B, Lee C-U, Lee C, Chae J-H. Low trait anxiety, high resilience, and their interaction as possible predictors for treatment response in patients with depression. J Affect Disord. 2012;137(1-3):61-9. doi:10.1016/j.jad.2011.12.026.

Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program.

Stewart JG, Harkness KL. Symptom specificity in the acute treatment of Major Depressive Disorder: a re-analysis of the treatment of depression collaborative research program. J Affect Disord. 2012;137(1-3):87-97. doi:10.1016/j.jad.2011.12.015.

Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA).

Hofmeijer-Sevink MK, Batelaan NM, van Megen HJGM, et al. Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2012;137(1-3):106-12. doi:10.1016/j.jad.2011.12.008.

The effects of progress monitoring on subsequent readmission to psychiatric care: a six-month follow-up.

Byrne SL, Hooke GR, Newnham EA, Page AC. The effects of progress monitoring on subsequent readmission to psychiatric care: a six-month follow-up. J Affect Disord. 2012;137(1-3):113-6. doi:10.1016/j.jad.2011.12.005.

Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study.

Havnes I, Bukten A, Gossop M, et al. Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study. Drug Alcohol Depend. 2012;124(3):307-10. doi:10.1016/j.drugalcdep.2012.02.005.

Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs).

Dennis ML, Scott CK. Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs). Drug Alcohol Depend. 2012;121(1-2):10-7. doi:10.1016/j.drugalcdep.2011.07.026.

Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings.

Guydish J, Ziedonis D, Tajima B, et al. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012;121(1-2):30-7. doi:10.1016/j.drugalcdep.2011.08.003.

Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study.

Consoli A, Raffin M, Laurent C, et al. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res. 2012;137(1-3):151-8. doi:10.1016/j.schres.2012.02.012.

Quite a bit of psych related updates in today's ASHP update

Hello all! Thought I would share in case some of you missed these updates. Enjoy and Happy Tuesday! Andy ---------- Forwarded message ---------- From: ashp_daily_briefing < ashp_daily_briefing@ashp.custombriefings.com > Date: Tue, Mar ...